Ian Clark

Ian Clark

Chairman presso OLEMA PHARMACEUTICALS, INC.

Patrimonio netto: 169 119 $ in data 29/02/2024

62 anni
Health Technology
Commercial Services
Consumer Non-Durables

Profilo

Mr. Ian T.
Clark
is a Chairman at Kyverna Therapeutics, Inc., a Chairman at Olema Pharmaceuticals, Inc., an Independent Outside Director at Takeda Pharmaceutical Co., Ltd., an Independent Director at Avrobio, Inc., an Independent Director at Corvus Pharmaceuticals, Inc., a Lead Independent Director at Guardant Health, Inc., a Chairman at X-Vax Technology, Inc., a Member at TechNet and a Vice President-Sales at IVAX Pharmaceuticals, Inc. He is on the Board of Directors at Asher Biotherapeutics, Inc., Takeda Pharmaceutical Co., Ltd., Avrobio, Inc., Corvus Pharmaceuticals, Inc. and Guardant Health, Inc. Mr. Clark was previously employed as a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, an Independent Director by Forty Seven, Inc., an Independent Director by Kite Pharma, Inc., an Independent Non-Executive Director by Shire Plc, an Independent Director by Agios Pharmaceuticals, Inc., an Independent Director by TerraVia Holdings, Inc., a Chief Executive Officer & Director by Genentech, Inc., a Chief Marketing Officer & Executive Vice President by Roche Group, a General Manager by Novartis Pharmaceuticals Canada, Inc., a Chief Operating Officer by Novartis Pharmaceuticals UK Ltd., a Vice President-Sales by Aventis SA, a Vice President-Sales & Marketing by IVAX LLC, a Vice President-Sales & Marketing by Sanofi, and a Member-BioFulcrum Board by The J.
David Gladstone Institutes.
He also served on the board at Shire Pharmaceuticals, Inc., Dendreon Corp., Dendreon Pharmaceuticals LLC, Biotechnology Innovation Organization, Gladstone Foundation (CA), Ligand UK Ltd., Solazyme, Inc., The Bioindustry Association, Vernalis (R&D) Ltd.
and Vernalis Therapeutics, Inc. He received his undergraduate degree from The University of Southampton.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
14/06/2023 8 901 ( 0.01% ) 169 119 $ 29/02/2024
08/02/2024 0 ( -.--% ) - $ 29/02/2024
16/06/2023 0 ( -.--% ) - $ 29/02/2024
06/06/2023 0 ( -.--% ) - $ 29/02/2024
06/12/2023 0 ( -.--% ) - $ 29/02/2024

Posizioni attive di Ian Clark

SocietàPosizioneInizio
CORVUS PHARMACEUTICALS, INC. Director/Board Member 03/01/2017
GUARDANT HEALTH, INC. Director/Board Member 01/12/2016
OLEMA PHARMACEUTICALS, INC. Chairman 01/08/2020
TAKEDA PHARMACEUTICAL COMPANY LIMITED Director/Board Member 01/01/2019
AVROBIO, INC. Director/Board Member 01/01/2018
KYVERNA THERAPEUTICS, INC. Chairman 15/09/2021
Corporate Officer/Principal -
Sales & Marketing -
Chairman -
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tutte le posizioni attive di Ian Clark

Precedenti posizioni note di Ian Clark

SocietàPosizioneFine
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Ian Clark

Formazione di Ian Clark

The University of Southampton Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ian Clark

Relazioni

99

Relazioni di 1° grado

35

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa8
SANOFI

Health Technology

AGIOS PHARMACEUTICALS, INC.

Health Technology

GUARDANT HEALTH, INC.

Health Services

CORVUS PHARMACEUTICALS, INC.

Health Technology

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Health Technology

AVROBIO, INC.

Health Technology

OLEMA PHARMACEUTICALS, INC.

Health Technology

KYVERNA THERAPEUTICS, INC.

Health Technology

Aziende private26

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Commercial Services

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Gladstone Foundation (CA)

Health Technology

Distribution Services

Health Technology

Commercial Services

Health Technology

Solazyme, Inc.

Health Technology

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Ian Clark